Purchases and Sales Made in Q4 2022 in Lyra Therapeutics, Inc. (LYRA)
This table provides information about the institutional ownership of Lyra Therapeutics, Inc. (LYRA) during Q4 2022. The information is specifically focused on institutions that hold shares of Lyra Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
BUY
|
- |
239K+ 378.14% |
$583K - $1.3M
|
302K
$60.4K
|
|
|
Feb 14, 2023
Q4 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
89.9K+ 158.0% |
$219K - $487K
|
147K
$29.4K
|
|
|
Feb 13, 2023
Q4 2022
|
Anson Funds Management LP
Dallas, TX |
BUY
|
- |
39.1KNew |
$95.5K - $212K
|
39.1K
$7.83K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
7.12K+ 7.53% |
$17.4K - $38.6K
|
102K
$20.4K
|
|
|
Feb 08, 2023
Q4 2022
|
Belpointe Asset Management LLC
|
BUY
|
- |
3.7KNew |
$9.04K - $20.1K
|
3.7K
$741
|
|
|
Feb 14, 2023
Q4 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
2.54K+ 7.24% |
$6.19K - $13.8K
|
37.6K
$7.52K
|
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
1.98K+ 1.35% |
$4.83K - $10.7K
|
149K
$29.8K
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.3K+ 37.13% |
$3.16K - $7.02K
|
4.79K
$957
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
1.1K+ 2.82% |
$2.68K - $5.96K
|
40.1K
$8.02K
|
|
|
Feb 14, 2023
Q4 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
333+ 210.76% |
$813 - $1.8K
|
491
$98.2
|
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
316+ 0.04% |
$771 - $1.71K
|
791K
$158K
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
303+ 9.79% |
$739 - $1.64K
|
3.4K
$679
|
|
|
Feb 10, 2023
Q4 2022
|
Core Cap Advisors, LLC
Southfield, MI |
BUY
|
- |
125New |
$305 - $678
|
125
$25
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
3+ 2.73% |
$7.32 - $16.3
|
113
$22.6
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
1New |
$2.44 - $5.42
|
1
$0.2
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-2.8K- 7.0% |
$6.83K - $15.2K
|
37.2K
$7.44K
|
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-7.98K- 37.0% |
$19.5K - $43.2K
|
13.6K
$2.72K
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-11.9K- 31.93% |
$28.9K - $64.3K
|
25.3K
$5.06K
|
|
|
Feb 14, 2023
Q4 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-14.2K- 33.18% |
$34.6K - $77K
|
28.6K
$5.72K
|
|
|
Feb 14, 2023
Q4 2022
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-25K- 1.11% |
$61K - $136K
|
2.22M
$444K
|
|
|
Feb 14, 2023
Q4 2022
|
Pura Vida Investments, LLC
New York, NY |
SELL
|
- |
-353K- 14.06% |
$861K - $1.91M
|
2.16M
$431K
|